(Q87942223)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24857830%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

title

Intestinal dysbiosis: novel mechanisms by which gut microbes trigger and prevent disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24857830%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

Mark A Underwood

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24857830%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

publication date

20 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24857830%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24857830%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24857830%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

page(s)

133-137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24857830%20AND%20SRC:MED&resulttype=core&format=json

A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice.

19 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Bifidobacteria stabilize claudins at tight junctions and prevent intestinal barrier dysfunction in mouse necrotizing enterocolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Gram negative bacteria are associated with the early stages of necrotizing enterocolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Preterm Birth and Necrotizing Enterocolitis Alter Gut Colonization in Pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

RETRACTED: The microbiota in inflammatory bowel disease in different age groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Specific Proliferative and Antibody Responses of Premature Infants to Intestinal Colonization with Nonpathogenic Probiotic E. coli Strain Nissle 1917

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Human intestinal microbiota gene risk factors for antibiotic-associated diarrhea: perspectives for prevention. Risk factors for antibiotic-associated diarrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Intestinal microbiota of infants with colic: development and specific signatures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Probiotic bacteria reduce salmonella typhimurium intestinal colonization by competing for iron

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

The Mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

The importance of pro-inflammatory signaling in neonatal necrotizing enterocolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Probiotics prevent necrotizing enterocolitis by modulating enterocyte genes that regulate innate immune-mediated inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

A molecular basis for bifidobacterial enrichment in the infant gastrointestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

The probiotic Escherichia coli strain Nissle 1917 induces gammadelta T cell apoptosis via caspase- and FasL-dependent pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Role of the intestinal microbiome in liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

TcpC protein from E. coli Nissle improves epithelial barrier function involving PKCζ and ERK1/2 signaling in HT-29/B6 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Stool microbiota and vaccine responses of infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Commensal and probiotic bacteria may prevent NEC by maturing intestinal host defenses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Cohort study of probiotics in a North American neonatal intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Intestinal epithelial apoptosis initiates gross bowel necrosis in an experimental rat model of neonatal necrotizing enterocolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

The microbiota of the gut in preschool children with normal and excessive body weight.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Gut metagenome in European women with normal, impaired and diabetic glucose control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Proteomic analysis of Bifidobacterium longum subsp. infantis reveals the metabolic insight on consumption of prebiotics and host glycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Genomic analysis identifies association of Fusobacterium with colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Microbial ecology: human gut microbes associated with obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Glycoprofiling of bifidobacterial consumption of human milk oligosaccharides demonstrates strain specific, preferential consumption of small chain glycans secreted in early human lactation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Fecal microbiota in premature infants prior to necrotizing enterocolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Towards the human colorectal cancer microbiome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Rapid determination of the bacterial composition of commercial probiotic products by terminal restriction fragment length polymorphism analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Fusobacterium is associated with colorectal adenomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Tumor necrosis factor receptor 1-dependent depletion of mucus in immature small intestine: a potential role in neonatal necrotizing enterocolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

A critical role for TLR4 induction of autophagy in the regulation of enterocyte migration and the pathogenesis of necrotizing enterocolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Probiotics for preterm neonates: what will it take to change clinical practice?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Genetics and environmental interactions shape the intestinal microbiome to promote inflammatory bowel disease versus mucosal homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Nursing our microbiota: molecular linkages between bifidobacteria and milk oligosaccharides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Salmonella, the host and its microbiota

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

More than a marine propeller--the flagellum of the probiotic Escherichia coli strain Nissle 1917 is the major adhesin mediating binding to human mucus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

The core gut microbiome, energy balance and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

An obesity-associated gut microbiome with increased capacity for energy harvest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

A comparison of two probiotic strains of bifidobacteria in premature infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Bifidobacterium longum subsp. infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate immune response, and the microbiota

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin-degradation in humanized rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

In vitro fermentability of human milk oligosaccharides by several strains of bifidobacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Gut inflammation provides a respiratory electron acceptor for Salmonella

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Host-derived nitrate boosts growth of E. coli in the inflamed gut

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

Paneth cell ablation in the presence of Klebsiella pneumoniae induces necrotizing enterocolitis (NEC)-like injury in the small intestine of immature mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2014.05.010

10.1016/J.YPMED.2014.05.010

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24857830%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference